Strategic advantages of insulin-like growth factor-I expression for cardioprotection

Journal of Gene Medicine

Volumn 5, Issue 4, 2003, Pages 277-286

  Chao, Wei ^a   Matsui, Takashi ^a   Novikov, Mikhail S ^a   Tao, Jingzang ^a   Li, Ling ^a   Liu, Heling ^a   Ahn, Youngkeun ^a   Rosenzweig, Anthony ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Apoptosis; Gene therapy; Growth factors; Ischemia

Indexed keywords

ADENOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; PROTEIN KINASE B; SOMATOMEDIN C; AKT1 PROTEIN, HUMAN; AKT1 PROTEIN, RAT; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; COCULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG BLOOD LEVEL; ENZYME ACTIVATION; GENE EXPRESSION; GENE TRANSFER; GENETIC CODE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; REPERFUSION INJURY; SOMATIC GENE THERAPY; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT; ADENOVIRUS; ANIMAL; CELL CULTURE; GENE THERAPY; GENE VECTOR; GENETICS; HEART MUSCLE; HEART MUSCLE CELL; HUMAN; METABOLISM; METHODOLOGY; PATHOLOGY; SIGNAL TRANSDUCTION;

ADENOVIRIDAE; ANIMALS; AUTOCRINE COMMUNICATION; CELLS, CULTURED; GENE THERAPY; GENETIC VECTORS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MYOCARDIAL ISCHEMIA; MYOCARDIUM; MYOCYTES, CARDIAC; PARACRINE COMMUNICATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION;

EID: 0642306140     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.347     Document Type: Article

References (29)

1. Haunstetter A, Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res 1998; 82: 1111-1129.
2. Narula J, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996; 335: 1182-1189.
3. Narula J, et al. Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci U S A 1999; 96:8144-8149.
4. Olivetti G, et al. Apoptosis in the failing human heart. N Engl J Med 1997; 336: 1131-1141.
5. Olivetti G, et al. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 1996; 28 2005-2016.
6. Cittadini A, et al. Insulin-like growth factor-1 but not growth hormone augments mammalian myocardial contractility by sensitizing the myofilament to Ca2+ through a wortmannin-sensitive pathway: studies in rat and ferret isolated muscles. Circ Res 1998; 83: 50-59.
7. Cittadini A, et al. Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation. Circulation 1996; 93: 800-809.
8. Buerke M, et al. Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci U S A 1995; 92: 8031-8035.
9. Reiss K, et al. Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. Proc Natl Acad Sci U S A 1996; 93: 8630-8635.
10. Redaelli G, et al. Effects of constitutive overexpression of insulin-like growth factor-1 on the mechanical characteristics and molecular properties of ventricular myocytes. Circ Res 1998; 82: 594-603.
11. Li B, et al. Insulin-like growth factor-1 attenuates the detrimental impact of nonocclusive coronary artery constriction on the heart. Circ Res 1999; 84: 1007-1019.
12. Yamashita K, et al. Reperfusion-activated Akt kinase prevents apoptosis in transgenic mouse hearts overexpressing insulin-like growth factor-1. Circ Res 2001; 88: 609-614.
13. Leri A, et al. Overexpression of insulin-like growth factor-1 attenuates the myocyte renin-angiotensin system in transgenic mice. Circ Res 1999; 84: 752-762.
14. Matsui T, et al. Adenoviral gene transfer of activated PI 3-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation 1999; 100: 2373-2379.
15. Fujio Y, et al. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 2000; 101: 660-667.
16. Matsui T, et al. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 2001; 104: 330-335.
17. Donath MY, et al. Cardiovascular and metabolic effects of insulin-like growth factor I at rest and during exercise in humans. J Clin Endocrinol Metab 1996; 81: 4089-4094.
18. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995; 16: 3-34.
19. Chan JM, et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998; 279: 563-566.
20. Hankinson SE, et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998; 351: 1393-1396.
21. Daughaday WH, et al. Characterization of somatomedin binding in human serum by ultracentrifugation and gel filtration, J Clin Endocrinol Metab 1982; 55: 916-921.
22. He T, et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998; 95: 2509-2514.
23. Shimatsu A, Rotwein P. Mosaic evolution of the insulin-like growth factors. Organization, sequence, and expression of the rat insulin-like growth factor I gene. J Biol Chem 1987; 262: 7894-7900.
24. Rosen CJ, Pollak M. Circulating IGF-I: new perspectives for a new century. Trends Endocrinol Metab 1999; 10(4): 136-141.
25. Barton-Davis ER, et al. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci U S A 1998; 95:15 603-15 607.
26. Musaro A, et al. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 an NF-ATc1. Nature 1999; 400: 581-585.
27. Rotwein P, et al. Organization and sequence of the human insulin-like growth factor I gene. Alternative RNA processing produces two insulin-like growth factor I precursor peptides. J Biol Chem 1986; 261: 4848-4832.
28. Rotwein P. Two insulin-like growth factor I messenger RNAs are expressed in human liver. Proc Natl Acad Sci U S A 1986; 83 77-81.
29. Melo LG, et al. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation 2002 105: 602-607.